ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Mesenchymal Stem Cells Market Regulations and Competitive … – LifePulseHealth

Mesenchymal Stem Cells Market Regulations and Competitive …LifePulseHealthThe increasing use of mesenchymal stem cells (MSCs) for the treatment of diseases and disabilities of the growing aging population is having a positive …and more &r… Continue reading

2017-09-14 Michael Zand NEWS

Mesenchymal Stem Cells Market Regulations and Competitive … – Digital Journal

Mesenchymal Stem Cells Market Regulations and Competitive …Digital JournalDigital Journal is a digital media news network with thousands of Digital Journalists in 200 countries around the world. Join us!and more &raquo… Continue reading

2017-09-14 Michael Zand NEWS

CardioBrief: Cardiac Stem Cell Therapies May Get Boost From New FDA – MedPage Today

CardioBrief: Cardiac Stem Cell Therapies May Get Boost From New FDAMedPage TodayCardiac stem cell therapy could gain FDA approval far earlier than most people expect, despite the fact that these therapies have consistently failed to produce any convinc… Continue reading

2017-09-14 Michael Zand NEWS

Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula – EurekAlert (press release)

Continue reading

2017-09-14 Michael Zand NEWS

Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula – EurekAlert (press release)

Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula
EurekAlert (press release)
14, 2017–A growing body of clinical evidence shows that transplantation of a patient’s own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn’s disease-related fistula can be a safe and effective addition to surgery.
Mesenchymal Stem Cells Market Regulations and Competitive Landscape Outlook to 2025Digital Journal

all 2 news articles »

Continue reading

2017-09-14 Michael Zand NEWS

Researchers Track Cancer Mutations Using CRISPR, Organoid Cultures – GenomeWeb

Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula
EurekAlert (press release)
14, 2017–A growing body of clinical evidence shows that transplantation of a patient’s own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn’s disease-related fistula can be a safe and effective addition to surgery.
Mesenchymal Stem Cells Market Regulations and Competitive Landscape Outlook to 2025Digital Journal

all 2 news articles »

Continue reading

2017-09-14 Michael Zand NEWS

Researchers Track Cancer Mutations Using CRISPR, Organoid Cultures – GenomeWeb

Researchers Track Cancer Mutations Using CRISPR, Organoid Cultures
GenomeWeb
NEW YORK (GenomeWeb) – Using two relatively new technologies — CRISPR-Cas9 genome editing and organoid culture techniques — researchers in the Netherlands and the UK have identified a specific DNA repair defect as the underlying cause of a …

Continue reading

2017-09-14 Michael Zand NEWS

Novartis and the Future of Gene Therapy – GuruFocus.com

Researchers Track Cancer Mutations Using CRISPR, Organoid Cultures
GenomeWeb
NEW YORK (GenomeWeb) – Using two relatively new technologies — CRISPR-Cas9 genome editing and organoid culture techniques — researchers in the Netherlands and the UK have identified a specific DNA repair defect as the underlying cause of a …

Continue reading

2017-09-14 Michael Zand NEWS
  • 1
  • …
  • 1,199
  • 1,200
  • 1,201
  • 1,202
  • 1,203
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Novartis and the Future of Gene Therapy
GuruFocus.com
Gene therapy is now, finally, a new weapon in our arsenal against cancer partly thanks to, of all things, the HIV virus. The world’s first chimeric antigen receptor T-cell (CAR-T) treatment was approved by the Food and Drug Administration at the end of …

and more »